Levetiracetam Terapia

Levetiracetam, the active ingredient in Levetiracetam Terapia, is an anticonvulsant presented as an oral tablet for oral use. It is employed to manage various seizure types in patients with epilepsy, including partial, generalized tonic‑clonic and myoclonic seizures.

GNH USA supplies Levetiracetam Terapia as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable sourcing for healthcare providers across multiple regions. All shipments are accompanied by full documentation to facilitate regulatory compliance.

Levetiracetam is an antiepileptic drug that reduces seizure activity across several seizure types.

- Partial seizures: reduces frequency of focal onset seizures in patients with epilepsy. - Generalized tonic‑clonic seizures: helps control convulsive seizures that involve the whole brain. - Myoclonic seizures: decreases sudden muscle jerks associated with myoclonic epilepsy.

Levetiracetam may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Dizziness: sensation of light‑headedness or unsteadiness, often transient. - Fatigue: feeling unusually tired or lacking energy, may affect daily activities. - Headache: mild to moderate cranial pain that can be intermittent. - Irritability: mood changes including increased agitation or restlessness.

Serious or Rare Side Effects: - Severe allergic reaction: rash, swelling, or difficulty breathing requiring immediate medical attention. - Mood or behavior changes: depression, suicidal thoughts, aggression, or hostility that may emerge suddenly. - Blood disorders: thrombocytopenia or leukopenia, presenting as easy bruising or increased infection risk.

When prescribing Levetiracetam, several precautions should be considered to ensure safe use.

- Renal impairment: adjust dose in patients with reduced kidney function. - History of psychiatric disorders: monitor for mood changes or aggression. - Concomitant CNS depressants: use caution as combined effects may increase sedation. - Pregnancy: risk unknown; evaluate benefit‑risk before use. - Driving and machinery: advise patients that dizziness or fatigue may affect performance. - Store at ambient temperature: keep below 25 °C in original packaging, protect from moisture.

Levetiracetam can interact with other medicines, influencing its effectiveness or safety.

Major Interactions (Avoid): - Carbamazepine: may reduce levetiracetam plasma levels, decreasing efficacy. - Phenobarbital: can lower levetiracetam concentrations, requiring monitoring.

Moderate Interactions (Monitor Closely): - Valproic acid: may increase risk of central nervous system side effects. - Fluoroquinolones: potential for enhanced neurotoxicity, watch for tremor or confusion. - Opioids: combined use may augment sedation and respiratory depression.